Exosomes derived from HCC cells can induce sorafenib resistance in vitro by activating HGF/MET/AKT signaling pathway and inhibiting in vitro and in vivo sorafenib-induced apoptosis [150]. The gene discussed is HGF; the disease is hepatocellular carcinoma.